Daily Archives: February 2, 2022

Higher vs Standard Adalimumab Induction Dosing Regimens and 2 Maintenance Strategies: Randomized SERENE CD Trial Results

Posted on February 2, 2022 by Gastroenterology Journal

Dose-optimization strategies for biologic therapies in Crohn’s disease (CD) are not well established. SERENE CD evaluated higher vs standard adalimumab induction dosing and clinically adjusted (CA) vs therapeutic drug monitoring (TDM) maintenance strat… Continue reading →

Posted in News | Comments Off on Higher vs Standard Adalimumab Induction Dosing Regimens and 2 Maintenance Strategies: Randomized SERENE CD Trial Results

Diminished Piezo2-dependent tactile sensitivity occurs in aging human gut and slows gastrointestinal transit in mice.

Posted on February 2, 2022 by Gastroenterology Journal
Posted in News | Comments Off on Diminished Piezo2-dependent tactile sensitivity occurs in aging human gut and slows gastrointestinal transit in mice.

Understanding early-onset colorectal cancer: The role of obesity

Posted on February 2, 2022 by Gastroenterology Journal
Posted in News | Comments Off on Understanding early-onset colorectal cancer: The role of obesity

Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future

Posted on February 2, 2022 by Gastroenterology Journal
Posted in News | Comments Off on Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future

Correction

Posted on February 2, 2022 by Gastroenterology

Dasgupta D, Nakao Y, Mauer AS, et al. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis. Gastroenterology 2020;159:1487–1503. Continue reading →

Posted in News | Comments Off on Correction